10489 related articles for article (PubMed ID: 1558997)
1. Malignant melanoma in association with phototherapy.
Bergner T; Przybilla B
Dermatology; 1992; 184(1):59-61. PubMed ID: 1558997
[TBL] [Abstract][Full Text] [Related]
2. Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study.
Wang E; Ahad T; Liu YA; Lee TK; Lui H; Crawford RI; Kalia S
J Am Acad Dermatol; 2024 Apr; 90(4):759-766. PubMed ID: 38070541
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulation of human leukocytes by staphylococcal enterotoxin A: augmentation of natural killer cells and induction of suppressor cells.
Platsoucas CD; Oleszak EL; Good RA
Cell Immunol; 1986 Feb; 97(2):371-85. PubMed ID: 2943428
[TBL] [Abstract][Full Text] [Related]
4. SIAscopy--a new non-invasive technique of melanoma diagnosis.
Michalska M; Chodorowska G; Krasowska D
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):421-31. PubMed ID: 16146122
[TBL] [Abstract][Full Text] [Related]
5. Cytokine production and antitumor effect of a nonreplicating, noncytopathic recombinant vaccinia virus expressing interleukin-12.
Meko JB; Tsung K; Norton JA
Surgery; 1996 Aug; 120(2):274-82; discussion 282-3. PubMed ID: 8751593
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and functional characterization of HTLV positive neoplastic T cells cultured with interleukin-2--I. Retention of morphology, phenotype and selective cytotoxic properties in long term culture.
Vyth-Dreese FA; de Vries JE
Leuk Res; 1984; 8(1):1-14. PubMed ID: 6321859
[TBL] [Abstract][Full Text] [Related]
7. Serum blocking factor as an index of metastatic spread following primary tumour excision.
Bray AE; Holt PG
Eur J Cancer (1965); 1975 Dec; 11(12):855-60. PubMed ID: 767115
[No Abstract] [Full Text] [Related]
8. Pharmacokinetics of human-mouse chimeric anti-GD2 mAb ch14.18 in a phase I trial in neuroblastoma patients.
Uttenreuther-Fischer MM; Huang CS; Yu AL
Cancer Immunol Immunother; 1995 Dec; 41(6):331-8. PubMed ID: 8635190
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 plus tumor necrosis factor alpha augments the antigenicity of melanoma cells.
Hoon DS; Hayashi Y; Morisaki T; Foshag LJ; Morton DL
Cancer Immunol Immunother; 1993 Nov; 37(6):378-84. PubMed ID: 8242663
[TBL] [Abstract][Full Text] [Related]
10. Different rates of ultraviolet-induced DNA damage in the epidermis and dermis of a platyfish model for carcinogenesis.
Ahmed FE
Radiat Environ Biophys; 1993; 32(3):259-70. PubMed ID: 8234656
[TBL] [Abstract][Full Text] [Related]
11. Tetramodality treatment of human melanoma in vitro.
Auzenne E; Feig B; Ross MI; Tomasovic SP; Klostergaard J
Melanoma Res; 1995 Feb; 5(1):49-57. PubMed ID: 7734956
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo activated memory T-lymphocytes as adoptive cellular therapy of human soft-tissue sarcoma targets with potentiation by cis-diamminedichloroplatinum(II).
Gold JE; Masters TR; Bloom ND; Shafir MK; Klein MJ; Kenan S; Osband ME
J Surg Oncol; 1995 Apr; 58(4):212-21. PubMed ID: 7723363
[TBL] [Abstract][Full Text] [Related]
13. Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line.
Blanchard SG; Harris CO; Ittoop OR; Nichols JS; Parks DJ; Truesdale AT; Wilkison WO
Biochemistry; 1995 Aug; 34(33):10406-11. PubMed ID: 7544613
[TBL] [Abstract][Full Text] [Related]
14. Control of growth and vascularity of B16 melanoma by syngeneic lymphocytes.
Gersten DM
Cell Biol Int Rep; 1980 Apr; 4(4):407-14. PubMed ID: 6156016
[TBL] [Abstract][Full Text] [Related]
15. Acid phosphatase activity in melanosomes.
Seiji M; Kikuchi A
J Invest Dermatol; 1969 Feb; 52(2):212-6. PubMed ID: 5774902
[No Abstract] [Full Text] [Related]
16. Malignant melanoma in fine needle aspirates and effusions. An immunocytochemical study using monoclonal antibodies.
Angeli S; Koelma IA; Fleuren GJ; Van Steenis GJ
Acta Cytol; 1988; 32(5):707-12. PubMed ID: 2458662
[TBL] [Abstract][Full Text] [Related]
17. Malignant schwannoma associated with xeroderma pigmentosum in a patient belonging to complementation group D.
Nakamura T; Ono T; Yoshimura K; Arao T; Kondo S; Ichihashi M; Matsumoto A; Fujiwara Y
J Am Acad Dermatol; 1991 Aug; 25(2 Pt 2):349-53. PubMed ID: 1894771
[TBL] [Abstract][Full Text] [Related]
18. Method for verifying the air kerma strength of I-125 plaques for the treatment of ocular melanoma.
Zimmermann LW; Wilkinson DA
J Appl Clin Med Phys; 2014 Jul; 15(4):4880. PubMed ID: 25207419
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymphadenectomy for cutaneous melanoma: who, what, and why.
Bower M; Scoggins CR
J Ky Med Assoc; 2009 Jul; 107(7):253-8. PubMed ID: 19678500
[TBL] [Abstract][Full Text] [Related]
20. A big gene linked to small eyes encodes multiple Mitf isoforms: many promoters make light work.
Yasumoto K; Amae S; Udono T; Fuse N; Takeda K; Shibahara S
Pigment Cell Res; 1998 Dec; 11(6):329-36. PubMed ID: 9870544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
